Grade II astrocytomas are subgrouped by chromosome aberrations

Cancer Genetics and Cytogenetics

Volumn 142, Issue 1, 2003, Pages 1-7

  Hirose, Yuichi ^a   Aldape, Kenneth D ^b   Chang, Susan ^a   Lamborn, Kathleen ^a   Berger, Mitchel S ^a   Feuerstein, Burt G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; CHILD; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 7Q; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME MICRODISSECTION; CHROMOSOME XP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC TRAIT; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

EID: 0345268776     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00791-4     Document Type: Article

References (42)

1. Kleihues P., Cavenee W.K. Pathology and genetics of tumors of the nervous system (World Health Organization classification of tumors). 2000;IARC Press, Lyon, France.
2. Daumas D.C. Histological grading of gliomas. Curr Opin Neurol Neurosurg. 5:1992;924-931.
3. Barker F.G., Prados M.D., Chang S.M., Gutin P.H., Lamborn K.R., Larson D.A., Malec M.K., McDermott M.W., Sneed P.K., Wara W.M., Wilson C.B. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg. 84:1996;442-448.
4. Vertosick F.T. Jr., Selker R.G., Arena V.C. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery. 28:1991;496-501.
5. Shibamoto Y., Kitakabu Y., Takahashi M., Yamashita J., Oda Y., Kikuchi H., Abe M. Supratentorial low-grade astrocytoma. Correlation of computed tomographic findings with effect of radiation therapy and prognostic values. Cancer. 72:1993;190-195.
6. Coons S.W., Johnson P.C., Scheithauer B.W., Yates A.J., Pearl D.K. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer. 79:1997;1381-1393.
7. Aldape K., Simmons M.L., Davis R.L., Miike R., Wiencke J., Barger G., Lee M., Chen P., Wrensch M. Discrepancies in diagnoses of neuroepithelial neoplasms. the San Francisco Bay area adult glioma study Cancer. 88:2000;2342-2349.
8. Smith J.S., Alderete B., Minn Y., Borell T.J., Perry A., Mohapatra G., Hosek S.M., Kimmel D., O'Fallon J., Yates A., Feuerstein B.G., Burger P.C., Scheithauer B.W., Jenkins R.B. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene. 18:1999;4144-4152.
9. Collins V.P., James C.D. Gene and chromosomal alterations associated with the development of human gliomas. FASEB J. 7:1993;926-930.
10. Sano T., Lin H., Chen X., Langford L.A., Koul D., Bondy M.L., Hess K.R., Myers J.N., Hong Y.K., Yung W.K., Steck P.A. Differential expression of MMAC/PTEN in glioblastoma multiforme. relationship to localization and prognosis Cancer Res. 59:1999;1820-1824.
11. Kleihues P., Ohgaki H. Primary and secondary glioblastoma. from concept to clinical diagnosis Neuro Oncol. 1:1999;44-51.
12. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Grey J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
13. Piper J., Rutovitz D., Sudar D., Kallioniemi A., Kallioniemi O.P., Waldman F.M., Grey J.W., Pinkel D. Computer image analysis of comparative genomic hybridization. Cytometry. 19:1995;10-26.
14. Mohapatra G., Moore D.H., Kim D.H., Grewal L., Hyun W.C., Waldman F.M., Pinkel D., Feuerstein B.G. Analysis of brain tumor cell lines confirm a simple model of relationship among fluroscence in situ hybridization, DNA index, and comparative genomic hybridization. Genes Chromosomes Cancer. 20:1997;311-319.
15. Weber R.G., Sabel M., Reifenberger J., Sommer C., Oberstraβ J., Reifenberger G., Kiessling M., Cremer T. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene. 13:1996;983-994.
16. Sallinen S.L., Sallinen P., Haapasalo H., Kononen J., Karhu R., Hélen P., Isola J. Accumulation of genetic change is associated with poor prognosis in grade II astrocytomas. Am J Pathol. 151:1997;1799-1807.
17. Nishizaki T., Ozaki S., Harada K., Ito H., Arai H., Beppu T., Sasaki K. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes Cancer. 21:1998;340-346.
18. Schröck E., Blume C., Meffert M.C., du Manoir S., Bersch W., Kiessling M., Lozanowa T., Thiel G., Witkoeski R., Ried T., Cremer T. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization. Genes Chromosomes Cancer. 15:1996;199-205.
19. Burger P.C., Scheithauer B.W. Tumors of the central nervous system. 3rd edition:1994;Armed Forces Institute of Pathology, Washington, DC. 25-44.
20. Hirose Y., Aldape K., Takahashi M., Berger M.S., Feuerstein B.G. Tissue microdissection and degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors. J Mol Diag. 3:2001;62-67.
21. Telenius H., Carter N.P., Rebb C.E., Nordenskjöld M., Ponder B.A.J., Tunnacliffe A. Degenerate oligonucleotide-primed PCR. general amplification of target DNA by single degenerate primer Genomics. 13:1992;718-725.
22. Kuukasjärvr T., Tanner M., Pennanen S., Karhu R., Visakorpi T., Isola J. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer. 18:1997;94-101.
23. Kim D.H., Mohapatra G., Bollen A., Waldman F.M., Feuerstein B.G. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer. 60:1995;812-819.
24. Wernicke C., Thiel G., Lozanowa T., Vogel S., Witkowski R. Numerical aberrations of chromosomes 1, 2, and 7 in astrocytomas studied by interphase cytogenetics. Genes Chromosomes Cancer. 19:1997;6-13.
25. Ranson D.T., Ritland S.R., Moertel C.A., Dahl R.J., O'Fallon J.R., Scheithauer B.W., Kimmel D.W., Kelly P.J., Olopade O.I., Diaz M.O., Jenkins R.B. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer. 5:1992;357-374.
26. Kappler R., Schlegel J., Kindler-Röhrborn A., Mennel H.D., Scherthan H. Comparative genomic in situ hybridization discloses recurrent gain of chromosome 4 in experimental gliomas of the rat. Cytogenet Cell Genet. 84:1999;194-198.
27. Kunwar S., Mohapatra G., Bollen A., Lamborn K.R., Prados M., Feuerstein B.G. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Cancer Res. 61:2001;7683-7688.
28. Mohapatra G., Bollen A.W., Kim D.H., Lamborn K., Moore D.H., Prados M.D., Feuerstein B.G. Genetic analysis of glioblastoma multiforme provides evidence for subgroup within the grade. Genes Chromosomes Cancer. 21:1998;195-206.
29. Giordano S., Ponzetto C., Di Renzo M.F., Cooper C.S., Comoglio P.M. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature. 335:1989;155-156.
30. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M.L., Kmiecik T.E., Vande Woude G.F., Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:1991;802-804.
31. Wullich B., Sattler H.P., Fischer U., Meese E. Two independent amplification events on chromosome 7 in glioma. amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET Anticancer Res. 15:1994;577-580.
32. Fischer U., Mueller H.W., Sattler H.P., Feiden K., Zang K.D., Meese E. Amplification of the MET gene in glioma. Genes Chromosomes Cancer. 12:1995;63-65.
33. Rosen E.M., Laterra J., Joseph A., Jin L., Fuchs A., Way D.E., Witte M., Weinand M., Goldberg I.D. Scatter factor expression and regulation in human glial tumors. Int J Cancer. 67:1996;248-255.
34. Hirose Y., Kojima M., Sagoh M., Murakami H., Yoshida K., Shimazaki K., Kawase T. Immunohistochemical examination of c-Met protein expression in astrocytic tumors. Acta Neuropathol. 95:1998;345-351.
35. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 10:1994;231-243.
36. Bentz M., Plesch A., Stilgenbauer S., Döhner H., Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer. 21:1998;172-175.
37. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., Collins C., Kuo W.L., Chen C., Zhai Y., Dairkee S.H., Ljung B.M., Gray J.W., Albertson D.G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 20:1998;207-211.
38. Jeuken J.W.M., Sprenger S.H.E., Wesseling P., Macville M.V.E., von Deimling A., Teepen H.L.J.M., van Overbeeke J.J., Boerman R.H. Identification of subgroups of high grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol. 58:1999;606-612.
39. Bigner S.H., Matthews M.R., Rasheed B.K.A., Wiltshire R.N., Friedman H.S., Friedman A.H., Stenzel T.T., Dawes D.M., McLendon R.E., Bigner D.D. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol. 155:1999;375-386.
40. Maintz D., Fiedler K., Koopmann J., Rollbrocker B., Nechev S., Lenartz D., Stangl A.P., Louis D.N., Schramm J., Wiestler O.D., von Deimling A. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol. 56:1997;1098-1104.
41. Cairncross J.G., Ueki K., Zlatescu M.C., Lisle D.K., Finkelstein D.M., Hammond R.R., Silver J.S., Stark P.C., Macdonald D.R., Ino Y., Ramsay D.A., Louis D.N. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 90:1998;1473-1479.
42. Smith J.S., Perry A., Borell T.J., Lee H.K., O'Fallon J., Hosek S.M., Kimmel D., Yates A., Burger P.C., Scheithauer B.W., Jenkins R.B. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol. 18:2000;636-645.